Trial
NCT01671488
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brown University
Collaborators
Rhode Island Hospital; The Miriam Hospital
Condition
Anal Cancer
Intervention
Treatment
Why stopped
pilot data to be used for upcoming larger trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-17